BETHKIS LOGO

Email

Home/Savings & Support/Chiesi CareDirect

Get started on BETHKIS® (Tobramycin Inhalation Solution) with savings and support

Chiesi CareDirect® is designed with the unique needs of CF patients in mind

Chiesi CareDirect is a program that helps you START, STAY, and SAVE on treatment. We’ll connect you with prescription and device access, financial assistance, and product counseling—all at no cost. If you use government-funded plans such as Medicaid, Medicare Part D, etc, you are not eligible for Chiesi CareDirect. See Terms and Conditions +.

Terms and Conditions

BETHKIS $0 Copay Assistance Program: is available to patients with commercial insurance. Patients pay $0 out-of-pocket costs toward their BETHKIS prescription up to a monthly maximum of $1440. To obtain this benefit, patients must be enrolled in Chiesi CareDirect and utilize one of the network specialty pharmacies. Upon enrollment, the offer is valid for 12 months of copay assistance. Patients with primary enrollment in government-funded plans are not eligible for copay assistance.

360° Debit Card: is available to patients with commercial insurance. Patients must call 1-888-865-1222 to sign up for the 360° Debit Card. For every qualifying monthly prescription of BETHKIS that is filled, the patient can receive $50 to apply toward goods and services including nutritional foods, food services, food preparation tools, vitamins, supplements, probiotics, fitness monitoring devices, pedometers, gym memberships, and expenses related to treatment visits. This offer covers up to $150 for each 3-month supply of BETHKIS. Patients receiving Medicare, Medicaid, or that are participating in any other state or federally subsidized pharmacy benefit program are not eligible for the 360° Debit Card offer. Chiesi reserves the right to rescind, revoke, or amend this offer without notice at any time. This offer is good only in the U.S. The card and offer expire on 12/31/18. Patients participating in the BETHKIS Patient Assistance Program are not eligible.

PAP eligibility requirements:

  • Legal US resident
  • Income level within specified guidelines
  • Uninsured or underinsured:
    • Commercially insured patients without prescription coverage are eligible
    • Commercially insured patients with no plan coverage for product are eligible
    • Commercially insured patients appealing plan determination are eligible (during the appeal process)
  • Patients with a Government Funded plan are not eligible for PAP (Medicare Part D, Medicaid, etc)
  • Commercially insured patients with high out-of-pocket costs are not considered eligible. Product is considered covered

$0 icon

$0 Copay Assistance Programs*

  • Eligible patients can pay as little as $0 per month
$50 icon

Receive up to $50 per month with the 360° Debit Card†‡

  • It is important that patients maintain a healthy lifestyle throughout treatment. You can use this credit on a variety of wellness-related items, such as:
    • Nutrition (Nutritional foods, food services, food preparation tools, vitamins, supplements, probiotics)
    • Fitness (Fitness-monitoring devices, pedometers, gym membership)
    • Additional support (Expenses related to treatment visits)
Phone icon

1-on-1 support with a dedicated Patient Navigator

  • Contact a personal Patient Navigator, 24 hours a day, 7 days a week
    • Get guidance on coverage, reimbursement, authorization, appeals, benefits, and more
    • Receive counseling and other resources
Kits icon

Free nebulizer kit and aerosol delivery system§

  • Get free PARI LC PLUS® nebulizer kits and Vios® Aerosol Delivery System
Hands icon

Patient Assistance Program*

  • Available for qualified patients who are uninsured or underinsured and cannot afford their medication
Supply icon

Free supply of BETHKIS with QuickStart*||

  • Patients can receive a free supply of BETHKIS

 

Take advantage of these helpful resources and enroll today!

Two easy ways to enroll:

Fill out this Service Request Form and bring it to your next doctor’s appointment

 

Fill out and send the following forms for more support

360° Debit Card Program Form

Chiesi CareDirect Patient Assistance Program Application

Contact a Chiesi CareDirect Specialist with any questions

9 am to 8 pm ET, Monday–Friday

1-888-865-1222 chiesicaredirect@caremetx.com

*Restrictions apply. Limit one card per person per month. Patients receiving Medicare, Medicaid, or that are participating in any other state or federally subsidized pharmacy benefit program are not eligible for certain components of this program. Please see full Terms and Conditions.

†Restrictions apply. Limit one card per person per month. Patients receive $50 per month with every BETHKIS refill (annual savings: $300). Patients receiving Medicare, Medicaid, or that are participating in any other state or federally subsidized pharmacy benefit program are not eligible for certain components of this program. Please see full Terms and Conditions.

‡A qualifying monthly prescription refill of BETHKIS consists of 1 treatment cycle of 28 days on/28 days off.

§Free PARI LC PLUS® nebulizer kit and Vios® Aerosol Delivery System may be available to eligible patients with a qualifying BETHKIS prescription.

||BETHKIS is shipped directly to patients and may also be available at doctor’s office.

Important Safety Information

Do not take BETHKIS® (Tobramycin Inhalation Solution) if you are allergic to tobramycin, or any of the ingredients in BETHKIS, or to any other aminoglycoside antibiotic.

Before you take BETHKIS, tell your health care provider if you have or have had hearing problems (ringing or other noises in your ears), dizziness, kidney problems, muscle weakness such as myasthenia gravis or Parkinson’s disease, breathing problems such as wheezing, coughing or chest tightness, or have had an organ transplant. Before you take BETHKIS, tell your health care provider if you are pregnant, plan to become pregnant, are breastfeeding or plan to breastfeed. It is not known if tobramycin in BETHKIS will pass into breast milk.

Tell your health care provider about all the medicines you take. Taking BETHKIS with certain other medications can cause serious side effects. If you are taking BETHKIS, you should discuss with your healthcare provider if you should take other medicines that may harm your nervous system, kidneys or hearing, or “water pills” (diuretics) such as Edecrin® (ethacrynic acid), Lasix® (furosemide), mannitol, or urea.

BETHKIS can cause serious side effects including hearing loss or ringing in the ears (ototoxicity), worsening kidney problems (nephrotoxicity), worsening muscle weakness, harm to an unborn baby, and/or severe breathing problems (bronchospasm). Tell your healthcare provider right away if you have hearing loss or hear noises in your ears (such as ringing or hissing), develop vertigo, dizziness, difficulty with balance, shortness of breath with wheezing, or coughing and chest tightness. Your healthcare provider may do a blood test and urine test to check how your kidneys are working while you are taking BETHKIS.

The most common side effects of BETHKIS include worsening of lung problems (decreased FEV), noisy breathing (rales), abnormal red blood cell sedimentation rate (determined by a blood test), and changes in your voice (hoarseness). Tell your health care provider about any side effect that bothers you or that does not go away.

About BETHKIS® (Tobramycin Inhalation Solution)

BETHKIS is a prescription medicine for people with cystic fibrosis (CF) who have lung infection with Pseudomonas aeruginosa bacteria. BETHKIS solution contains tobramycin, an aminoglycoside antibiotic.

It is not known if BETHKIS is safe and effective in children under 6 years of age, in people who have decreased lung volume (FEV1 less than 40% predicted), in people who have lung infection with Burkholderia cepacia bacteria, or when BETHKIS is used for more than 3 on/off cycles.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Patient Information within the accompanying Full Prescribing Information.

This website is intended for United States residents only.
References available upon request.

Terms and Conditions

BETHKIS $0 Copay Assistance Program: is available to patients with commercial insurance. Patients pay $0 out-of-pocket costs toward their BETHKIS prescription up to a monthly maximum of $1440. To obtain this benefit, patients must be enrolled in Chiesi CareDirect and utilize one of the network specialty pharmacies. Upon enrollment, the offer is valid for 12 months of copay assistance. Patients with primary enrollment in government-funded plans are not eligible for copay assistance.

360° Debit Card: is available to patients with commercial insurance. Patients must call 1-888-865-1222 to sign up for the 360° Debit Card. For every qualifying monthly prescription of BETHKIS that is filled, the patient can receive $50 to apply toward goods and services including nutritional foods, food services, food preparation tools, vitamins, supplements, probiotics, fitness monitoring devices, pedometers, gym memberships, and expenses related to treatment visits. This offer covers up to $150 for each 3-month supply of BETHKIS. Patients receiving Medicare, Medicaid, or that are participating in any other state or federally subsidized pharmacy benefit program are not eligible for the 360° Debit Card offer. Chiesi reserves the right to rescind, revoke, or amend this offer without notice at any time. This offer is good only in the U.S. The card and offer expire on 12/31/18. Patients participating in the BETHKIS Patient Assistance Program are not eligible.

PAP eligibility requirements:
  • Legal US resident
  • Income level within specified guidelines
  • Uninsured or underinsured:
    • Commercially insured patients without prescription coverage are eligible
    • Commercially insured patients with no plan coverage for product are eligible
    • Commercially insured patients appealing plan determination are eligible (during the appeal process)
  • Patients with a Government Funded plan are not eligible for PAP (Medicare Part D, Medicaid, etc)
  • Commercially insured patients with high out-of-pocket costs are not considered eligible. Product is considered covered

Are you a US patient, caregiver, or healthcare professional?

I AM A PATIENT/CAREGIVER

- or -

I AM A HEALTHCARE PROFESSIONAL

FOR HEALTHCARE PROFESSIONALS

The page you requested is intended for US healthcare professionals only.

I certify that I am US healthcare professional.

YESNO

Send this site to a friend

Someone you know may be interested in learning more about BETHKIS® (Tobramycin Inhalation Solution). Simply complete all fields below and then submit to share this information.

Recipient's Name

Recipient's Email Address

Your Name

Your Email Address

The following message will be sent to the recipient:

Dear [NAME],

I thought you might be interested in learning more about BETHKIS® (Tobramycin Inhalation Solution), an inhaled prescription medication for cystic fibrosis (CF) patients infected by Pseudomonas aeruginosa.

BETHKIS is an inhaled antibacterial solution prescribed to patients with CF whose lungs contain bacteria called Pseudomonas aeruginosa. BETHKIS delivers the same amount of antibiotic as other available nebulized tobramycin products (300 mg) in only 4 mL. Approximately 15 minutes to administer with PARI LC PLUS®.

The most common side effects of BETHKIS include worsening of lung problems, noisy breathing, abnormal red blood cell sedimentation rate (determined by a blood test), and changes in your voice (hoarseness).

Scroll down for Important Safety Information.

You can learn more about this treatment at patient.bethkis.com.

Important Safety Information

Do not take BETHKIS® (Tobramycin Inhalation Solution) if you are allergic to tobramycin, or any of the ingredients in BETHKIS, or to any other aminoglycoside antibiotic.

Before you take BETHKIS, tell your health care provider if you have or have had hearing problems (ringing or other noises in your ears), dizziness, kidney problems, muscle weakness such as myasthenia gravis or Parkinson’s disease, breathing problems such as wheezing, coughing or chest tightness, or have had an organ transplant. Before you take BETHKIS, tell your health care provider if you are pregnant, plan to become pregnant, are breastfeeding or plan to breastfeed. It is not known if tobramycin in BETHKIS will pass into breast milk.

Tell your health care provider about all the medicines you take. Taking BETHKIS with certain other medications can cause serious side effects. If you are taking BETHKIS, you should discuss with your healthcare provider if you should take other medicines that may harm your nervous system, kidneys or hearing, or “water pills” (diuretics) such as Edecrin® (ethacrynic acid), Lasix® (furosemide), mannitol, or urea.

BETHKIS can cause serious side effects including hearing loss or ringing in the ears (ototoxicity), worsening kidney problems (nephrotoxicity), worsening muscle weakness, harm to an unborn baby, and/or severe breathing problems (bronchospasm). Tell your healthcare provider right away if you have hearing loss or hear noises in your ears (such as ringing or hissing), develop vertigo, dizziness, difficulty with balance, shortness of breath with wheezing, or coughing and chest tightness. Your healthcare provider may do a blood test and urine test to check how your kidneys are working while you are taking BETHKIS.

The most common side effects of BETHKIS include worsening of lung problems (decreased FEV), noisy breathing (rales), abnormal red blood cell sedimentation rate (determined by a blood test), and changes in your voice (hoarseness). Tell your health care provider about any side effect that bothers you or that does not go away.


About BETHKIS® (Tobramycin Inhalation Solution)

BETHKIS is a prescription medicine for people with cystic fibrosis (CF) who have lung infection with Pseudomonas aeruginosa bacteria. BETHKIS solution contains tobramycin, an aminoglycoside antibiotic.

It is not known if BETHKIS is safe and effective in children under 6 years of age, in people who have decreased lung volume (FEV1 less than 40% predicted), in people who have lung infection with Burkholderia cepacia bacteria, or when BETHKIS is used for more than 3 on/off cycles.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Patient Information within the accompanying Full Prescribing Information.

This website is intended for United States residents only.

BETHKIS® is a registered trademark of Chiesi Farmaceutici, S.p.A.
PARI LC PLUS® and Vios® are registered trademarks of PARI Respiratory Equipment, Inc.
©2018 Chiesi, Inc. All rights reserved.
Created in the USA. PP-B-0045 V2.0